#ICYMI The Community Health Center of Buffalo, Inc. and Cerebro NeuroTech, Inc. demonstrated the use of Artificial Intelligence in detecting traumatic brain injuries during a press conference held on December 2. Check out the WBFO "What's Next?" show to learn more … Guest host Naila Ansari spoke with Paolo Alejandro Catilo, CEO, Cerebro NeuroTech, Inc.; Dr. LaVonne Ansari, PhD, CEO/executive director, Community Health Center of Buffalo, Inc.; Dr. Kenyani Davis, MD, MPH, chief medical officer, Community Health Center of Buffalo, Inc.; and Kristian Bouw, chief technology officer, Cerebro NeuroTech, Inc. https://lnkd.in/ge46-GVj
Community Health Center of Buffalo, Inc.’s Post
More Relevant Posts
-
🔥 Hot off the press! 🔥 👉 Mental stress is a known cardiovascular risk factor, especially in #women. 👉 The #amygdala, our brain's center for managing fear and negative emotions, shows activity levels that closely match reported stress levels. 👉 Could positron emission tomography (#PET) imaging of the amygdala be the key to better risk stratification in cardiovascular patients? 💡 Dive into the details of our interdisciplinary study, the first of its kind in #Europe, now published in the European Heart Journal: https://lnkd.in/ehK3Ye2F #HeartHealth #MentalStress #CardiovascularResearch #PETScans #EuropeanHeartJournal #InnovativeResearch #gebhardlab Nidaa Mikail, Prof. Dr. med. Ronny Ralf Büchel, Prof. Dr. med. Christoph Gräni, Alexia Rossi, Haider Achi, Susan Bengs, PhD, Vera Regitz-Zagrosek, Atanas Todorov, MD-PhD, Caroline Gebhard, MD, Valerie Treyer, Susanne Wegener, PD Dr. med. Aju Pazhenkottil MD FESC
To view or add a comment, sign in
-
Did you know that our equipment plays a key role in supporting those working in vascular research? It’s World Heart Day, and we’re spotlighting how our industry-leading solutions contribute to research into vascular health and improving patient outcomes 💙 For example, both our InvivO₂ 300 and Sci-tive workstations offer precise control that mimics in vivo conditions, allowing researchers to study even the most complex cell interactions. Read the case study on our website now: https://lnkd.in/enpekWfs #casestudy #scientificresearch #worldheartday
To view or add a comment, sign in
-
-
🌟 Navigating the Complexity of Tremor and Dystonia 🌟 Tremor and dystonia are intriguing movements that often coexist, yet they present unique challenges in their descriptions. Tremor, rhythmical and oscillatory, stands in contrast to the sustained or repetitive postures of dystonia. Sometimes these movements occur in the same body region, creating a puzzle for clinicians to untangle. The term "dystonic tremor" has sparked much debate, initially distinguishing tremor-like movements in dystonia from more common types. However, its usage has expanded and often overlaps with other terms like "tremor associated with dystonia" and "dystonia-tremor syndrome." 🏥 A team of specialists is pushing for clarity! By reviewing and refining terminology, they aim to simplify how we describe these conditions. Clear, consistent terms can empower clinicians to make informed decisions and potentially integrate future tools like motion analysis for better diagnosis. Understanding tremor and dystonia's coexistence is crucial for advancing patient care. Let's keep challenging and redefining our approach for a clearer path forward! 🧠 Read Research 👉🏻 https://lnkd.in/d5sNerT7 #research #pubmed
To view or add a comment, sign in
-
Exciting developments in the understanding of Multiple Sclerosis (MS) have emerged, thanks to the dedicated efforts of EVERSANA! Our latest blog post, authored by Elizabeth Halloran, Abril Oliva Ramírez and Sumeet Singh, in collaboration with coauthors from the University of Buffalo, Janssen Scientific Affairs, Certara USA and the Ottawa Hospital Research Institute, delves into groundbreaking findings on brain volume loss in MS patients. Discover how these insights could pave the way for innovative treatments and improved patient outcomes: https://ow.ly/eKHP50TWfqu. #MultipleSclerosis #BrainHealth #MedicalResearch
To view or add a comment, sign in
-
-
In honor of Healthy Vision Month, we’re highlighting a recent discovery in vision loss prevention from UVA Health School of Medicine scientists. Ambati Jayakrishna, MD, Shao-bin Wang, PhD, and colleagues have identified a potential new target to prevent the formation of abnormal tangles of blood vessels. Abnormal vessel overgrowth is typically associated with vision impairment and eye conditions such as neovascular age-related macular degeneration. Ambati and Wang’s new research not only deepens the medical community’s current understanding of vision loss but also opens possibilities for cost-effective and accessible treatments, avoiding drug resistance concerns found in conventional anti-VEGF therapies. Read their overview here: https://loom.ly/8VEf5DA - #VCCRN #clinicalresearch #visionhealth #clinicalbreakthrough
To view or add a comment, sign in
-
-
🚀 Excited to share a recent group project: a Brain Disease Detection System designed to leverage Artificial Intelligence and Data Science for early and accurate diagnosis of neurological conditions. 🧠💡 Watch the video to see how the team developed this innovative solution, demonstrating the power of technology in transforming healthcare. Please note: Certain parts of the video are blurred for privacy purposes. #DataScience #ArtificialIntelligence #HealthcareInnovation #BrainDiseaseDetection #TechForGood #IITSriLanka
To view or add a comment, sign in
-
Exciting progress in neuroprosthetics! The LUKE Arm clinical trial, led by Dr. Jacob George, is now testing this advanced bionic arm in real-world settings. This marks a major step in improving independence and mobility for individuals with limb loss. Read more about this groundbreaking work: https://lnkd.in/dQHtiDwm Jacob A. George Craig H. Neilsen Rehabilitation Hospital
To view or add a comment, sign in
-
-
Real scientists. Real science.
GMH Chief Medical Scientist Prof. Talma Hendler was on the stage at the Real-Time Functional Imaging and Neurofeedback meeting | rtFIN 2024 in Heidelberg, Germany together with scientists from around the world. Prof Hendler shared insights on how scientific findings were translated into an FDA-cleared self-neuromodulation device for treating PTSD. Curious about Prism's journey from the research lab to treating patients in the clinic? Learn more here: https://lnkd.in/dGxV2hRy Rani Cohen | Oded Kraft
To view or add a comment, sign in
-
-
At #AES2024, Jacqueline A. French, MD, of NYU Grossman School of Medicine, discussed how innovative startups are using proof-of-concept studies and devices like responsive neurostimulators to improve patient outcomes. #Epilepsy American Epilepsy Society 👉 Watch Now: https://lnkd.in/e4hkJNpz
To view or add a comment, sign in
-
-
Neurotech Pub returns! We've already recorded three great episodes to be released this summer. This episode was a great conversation that ranges from the physics of wireless power transfer to the challenges of being a scientist-entrepeneur. Let me know what you think!
🚨 Don't miss the season 3 premiere of Neurotech Pub! Join our CEO, Matt Angle, and leading experts Jacob Robinson from Motif Neurotech, Grayson Z. from Resonant Link, and Alexander Yeh from Neuspera Medical Inc. as they discuss the groundbreaking developments in wireless power technologies for implantable devices. From high data rate brain-computer interfaces to life-changing mental health treatments, this episode is packed with insights on the future of neurotech. 🎙️🧠 Listen to the full episode: https://lnkd.in/gdDjG_6e #NeurotechPub #BCI
To view or add a comment, sign in